Relationship between mammographic features and hormone receptor content in patients with breast cancer

G. R. Ainge, Robert Choplin, R. E. Bechtold, H. B. Muss, L. D. Case, T. E. Kute

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Recurrences of breast cancer are more responsive to hormone therapy if the tumors are positive for estrogen receptors or progesterone receptors. To assess the relationship between hormone receptor content, mammographic tumor morphology, and breast parenchymal patterns, we reviewed charts and mammograms of 210 patients with primary unilateral breast cancer. Mammograms of tumors in 97 patients were divided morphologically into five groups: (1) spiculated mass, (2) architectural distortion, (3) calcifications only, (4) circumscribed mass, and (5) tumor not visible. Estrogen receptor positivity was 81% (39/48) in group 1, 37% (7/19) in group 2, 17% (2/12) in group 3, 31% (4/13) in group 4, and 60% (3/5) in group 5 (P <.001). Mean estrogen receptor content was also significantly different among groups (P <.001). There was no statistically significant association between tumor morphology and progesterone receptors, or between calcifications and receptor status. In all 210 patients, hormone-receptor-positive tumors showed no association with mammographic parenchymal pattern. When direct assay of estrogen receptors is unavailable, mammographic appearance of the tumor may suggest the estrogen receptor status.

Original languageEnglish (US)
Pages (from-to)1506-1511
Number of pages6
JournalSouthern Medical Journal
Volume82
Issue number12
StatePublished - 1989
Externally publishedYes

Fingerprint

Estrogen Receptors
Hormones
Breast Neoplasms
Neoplasms
Progesterone Receptors
Recurrence
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Ainge, G. R., Choplin, R., Bechtold, R. E., Muss, H. B., Case, L. D., & Kute, T. E. (1989). Relationship between mammographic features and hormone receptor content in patients with breast cancer. Southern Medical Journal, 82(12), 1506-1511.

Relationship between mammographic features and hormone receptor content in patients with breast cancer. / Ainge, G. R.; Choplin, Robert; Bechtold, R. E.; Muss, H. B.; Case, L. D.; Kute, T. E.

In: Southern Medical Journal, Vol. 82, No. 12, 1989, p. 1506-1511.

Research output: Contribution to journalArticle

Ainge, GR, Choplin, R, Bechtold, RE, Muss, HB, Case, LD & Kute, TE 1989, 'Relationship between mammographic features and hormone receptor content in patients with breast cancer', Southern Medical Journal, vol. 82, no. 12, pp. 1506-1511.
Ainge, G. R. ; Choplin, Robert ; Bechtold, R. E. ; Muss, H. B. ; Case, L. D. ; Kute, T. E. / Relationship between mammographic features and hormone receptor content in patients with breast cancer. In: Southern Medical Journal. 1989 ; Vol. 82, No. 12. pp. 1506-1511.
@article{084d389402e542078101323375b51778,
title = "Relationship between mammographic features and hormone receptor content in patients with breast cancer",
abstract = "Recurrences of breast cancer are more responsive to hormone therapy if the tumors are positive for estrogen receptors or progesterone receptors. To assess the relationship between hormone receptor content, mammographic tumor morphology, and breast parenchymal patterns, we reviewed charts and mammograms of 210 patients with primary unilateral breast cancer. Mammograms of tumors in 97 patients were divided morphologically into five groups: (1) spiculated mass, (2) architectural distortion, (3) calcifications only, (4) circumscribed mass, and (5) tumor not visible. Estrogen receptor positivity was 81{\%} (39/48) in group 1, 37{\%} (7/19) in group 2, 17{\%} (2/12) in group 3, 31{\%} (4/13) in group 4, and 60{\%} (3/5) in group 5 (P <.001). Mean estrogen receptor content was also significantly different among groups (P <.001). There was no statistically significant association between tumor morphology and progesterone receptors, or between calcifications and receptor status. In all 210 patients, hormone-receptor-positive tumors showed no association with mammographic parenchymal pattern. When direct assay of estrogen receptors is unavailable, mammographic appearance of the tumor may suggest the estrogen receptor status.",
author = "Ainge, {G. R.} and Robert Choplin and Bechtold, {R. E.} and Muss, {H. B.} and Case, {L. D.} and Kute, {T. E.}",
year = "1989",
language = "English (US)",
volume = "82",
pages = "1506--1511",
journal = "Southern Medical Journal",
issn = "0038-4348",
publisher = "Lippincott Williams and Wilkins",
number = "12",

}

TY - JOUR

T1 - Relationship between mammographic features and hormone receptor content in patients with breast cancer

AU - Ainge, G. R.

AU - Choplin, Robert

AU - Bechtold, R. E.

AU - Muss, H. B.

AU - Case, L. D.

AU - Kute, T. E.

PY - 1989

Y1 - 1989

N2 - Recurrences of breast cancer are more responsive to hormone therapy if the tumors are positive for estrogen receptors or progesterone receptors. To assess the relationship between hormone receptor content, mammographic tumor morphology, and breast parenchymal patterns, we reviewed charts and mammograms of 210 patients with primary unilateral breast cancer. Mammograms of tumors in 97 patients were divided morphologically into five groups: (1) spiculated mass, (2) architectural distortion, (3) calcifications only, (4) circumscribed mass, and (5) tumor not visible. Estrogen receptor positivity was 81% (39/48) in group 1, 37% (7/19) in group 2, 17% (2/12) in group 3, 31% (4/13) in group 4, and 60% (3/5) in group 5 (P <.001). Mean estrogen receptor content was also significantly different among groups (P <.001). There was no statistically significant association between tumor morphology and progesterone receptors, or between calcifications and receptor status. In all 210 patients, hormone-receptor-positive tumors showed no association with mammographic parenchymal pattern. When direct assay of estrogen receptors is unavailable, mammographic appearance of the tumor may suggest the estrogen receptor status.

AB - Recurrences of breast cancer are more responsive to hormone therapy if the tumors are positive for estrogen receptors or progesterone receptors. To assess the relationship between hormone receptor content, mammographic tumor morphology, and breast parenchymal patterns, we reviewed charts and mammograms of 210 patients with primary unilateral breast cancer. Mammograms of tumors in 97 patients were divided morphologically into five groups: (1) spiculated mass, (2) architectural distortion, (3) calcifications only, (4) circumscribed mass, and (5) tumor not visible. Estrogen receptor positivity was 81% (39/48) in group 1, 37% (7/19) in group 2, 17% (2/12) in group 3, 31% (4/13) in group 4, and 60% (3/5) in group 5 (P <.001). Mean estrogen receptor content was also significantly different among groups (P <.001). There was no statistically significant association between tumor morphology and progesterone receptors, or between calcifications and receptor status. In all 210 patients, hormone-receptor-positive tumors showed no association with mammographic parenchymal pattern. When direct assay of estrogen receptors is unavailable, mammographic appearance of the tumor may suggest the estrogen receptor status.

UR - http://www.scopus.com/inward/record.url?scp=0024827278&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024827278&partnerID=8YFLogxK

M3 - Article

C2 - 2688129

AN - SCOPUS:0024827278

VL - 82

SP - 1506

EP - 1511

JO - Southern Medical Journal

JF - Southern Medical Journal

SN - 0038-4348

IS - 12

ER -